Lack of Association of IL-10 Promoter Gene Variants with Type 1 Diabetes in a French Population

Human Immunology

Volumn 67, Issue 4-5, 2006, Pages 311-317

  Reynier, Frederic ^a   Cazalis, Marie Angelique ^a   Lecoq, Annick ^c   Paye, Malick ^b   Rosa, Audrey ^c   Durand, Annie ^c   Jhumka, Umar ^a   Mougin, Bruno ^a,b   Miossec, Pierre ^a,d   Bendelac, Nathalie ^d   Nicolino, Marc ^c,d   Thivolet, Charles ^c,d  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b BIOMÉRIEUX   (France)

^c INSERM   (France)

^d HOSPICES CIVILS DE LYON   (France)

Author keywords

diabetes; genetic susceptibility; IL 10

Indexed keywords

GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; IA ANTIBODY; INTERLEUKIN 10;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRANCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE;

EID: 33646721330     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.02.029     Document Type: Article

References (27)

1. Mein C.A., Esposito L., Dunn M.G., Johnson G.C., Timms A.E., Goy J.V., Smith A.N., Sebag-Montefiore L., Merriman M.E., Wilson A.J., Pritchard L.E., Cucca F., Barnett A.H., Bain S.C., and Todd J.A. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 19 (1998) 297
2. Concannon P., Gogolin-Ewens K.J., Hinds D.A., Wapelhorst B., Morrison V.A., Stirling B., Mitra M., Farmer J., Williams S.R., Cox N.J., Bell G.I., Risch N., and Spielman R.S. A second-generation screen of the human genome for susceptibility to insulin dependent diabetes mellitus. Nat Genet 19 (1998) 292
3. Almawi W.Y., Tamim H., and Azar S.T. T helper type 1 and type 2 cytokines mediate the onset and progression of Type 1 (Insulin-Dependent) Diabetes. J Clin Endocrinol Metab 84 (1999) 1497
4. Wogensen L., Lee M.S., and Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in non-obese diabetic mice. J Exp Med 179 (1994) 1379
5. Moritani M., Yoshimoto K., Ii S., Kondo M., Iwahana H., Yamaoka T., Sano T., Nakano N., Kikutani H., and Itakura M. Prevention of adoptively transferred diabetes in non-obese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes. J Clin Invest 98 (1996) 1851
6. Lee M.S., Mueller R., Wicker L.S., Peterson L.B., and Sarvetnick N. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J Exp Med 183 (1996) 2663
7. Llorente L., Richaud-Patin Y., Fior R., Alcocer-Varela J., Wijdenes J., Fourrier B.M., Galanaud P., and Emilie D. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37 (1994) 1647
8. Eskdale J., and Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 42 (1995) 444
9. Eskdale J., Kube D., and Gallagher G. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene. Immunogenetics 45 (1996) 82
10. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1
11. Hulkkonen J., Pertovaara M., Antonen J., Lahdenpohja N., Pasternack A., and Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome. Arthritis Rheum 44 (2001) 176
12. Crawley E., Kai R., Sillibourne J., Patel P., Hutchinson I., and Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Arthritis. Rheum 42 (1999) 1101
13. Geranton S., Rostagnat-Stefanutti A., Bendelac N., Cerrato E., Barbalat V., Leissner P., Nicolino M., Thivolet C., and Mougin B. High-risk genotype for type 1 diabetes. a new simple microtiter plate-based ELOSA assay. Genet Test 7 (2003) 7
14. Thivolet C., Nicolino M., Monbeig S., Estour B., Halimi S., Robert M., Orgiazzi J., and Chatelain P. GRADI study: Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large French cohort of family members. Diab Metabol 28 (2002) 279
15. Bingley P.J., Bonifacio E., and Mueller P.W. Diabetes Antibody Standardization Program. first assay proficiency evaluation. Diabetes 52 (2003) 1128
16. Hara M., Kingsley C.I., Niimi M., Read S., Turvey S.E., Bushell A.R., Morris P.J., Powrie F., and Wood K.J. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166 (2001) 3789
17. Eskdale J., Kube D., Tesch H., and Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 46 (1997) 120
18. Kube D., Platzer C., von Knethen A., Straub H., Bohlen H., Hafner M., and Tesch H. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 7 (1995) 1
19. Westendorp R.G., Langermans J.A., Huizinga T.W., Verweij C.L., and Sturk A. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349 (1997) 170
20. Urcelay E., Santiago J.L., de la Calle H., Martinez A., Figueredo A., Fernandez-Arquero M., and de la Concha E.G. Interleukin-10 polymorphisms in Spanish type 1 diabetes patients. Genes Immun 5 (2004) 306
21. Tegoshi H., Hasegawa G., Obayashi H., Nakano K., Kitagawa Y., Fukui M., Matsuo S., Deguchi M., Ohta M., Nishimura M., Nakamura N., and Yoshikawa T. Polymorphisms of interferon-γ gene CA-repeat and interleukin-10 promoter region (-592A/C) in Japanese type 1 diabetes. Hum Immunol 63 (2002) 121
22. Ide A., Kawasaki E., Abiru N., Sun F., Takahashi R., Kuwahara H., Fujita N., Kita A., Oshima K., Sakamaki H., Uotani S., Yamasaki H., Yamaguchi Y., and Eguchi K. Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum Immunol 63 (2002) 690
23. Rady P.L., Matalon R., Grady J., Smith E.M., Hudnall S.D., Kellner L.H., Nitowsky H., Tyring S.K., and Hughes T.K. Comprehensive analysis of genetic polymorphisms in the interleukin-10 promoter. implications for immune regulation in specific ethnic populations. Genet Test 8 (2004) 194
24. Gibson A.W., Edberg J.C., Wu J., Westendorp R.G., Huizinga T.W., and Kimberly R.P. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166 (2001) 3915
25. Balasa B., and Sarvetnick N. Cytokines and IDDM. implications for etiology and therapy. Drug News Perspect 11 (1998) 356
26. Rotter J.I., and Landaw E.M. Measuring the genetic contribution of a single locus to a multilocus disease. Clin Genet 26 (1984) 529
27. Noble J.A., Valdes A.M., Cook M., Klitz W., Thomson G., and Erlich H.A. The role of HLA class II genes in insulin-dependent diabetes mellitus. molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 59 (1996) 1134